Related Experiment Video
Updated: Jul 2, 2026
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Novel potential therapies for septic shock.
Shock (Augusta, Ga.)
|August 16, 2008
Summary
Sepsis, a critical condition from infection, and septic shock, its severe form, still have high mortality. This review covers current treatments and novel therapies for sepsis to improve patient outcomes.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pathophysiology of sepsis
Background:
- Sepsis is a systemic inflammatory response to infection.
- Septic shock, a severe complication, presents with refractory hypotension and is often fatal.
- Despite advances, sepsis morbidity and mortality remain high.
Discussion:
- Current standard treatments for septic shock focus on prompt diagnosis and management.
- Novel therapies aim to enhance hemodynamic support and modulate the inflammatory response.
- These emerging treatments have shown promise in experimental and clinical studies.
Key Insights:
- Understanding sepsis pathophysiology is crucial for effective treatment.
- Multifaceted therapeutic strategies are needed to combat sepsis.
- Early intervention and advanced therapies can improve septic shock survival rates.
Outlook:
- Continued research into novel sepsis therapies is essential.
- Randomized controlled trials are vital for validating new treatment approaches.
- Improving sepsis management will reduce global health burdens.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).